Glucotrack (GCTK) EBIAT (2016 - 2020)
Historic EBIAT for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$879000.0.
- Glucotrack's EBIAT fell 11366.33% to -$879000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$2.7 million, marking a year-over-year decrease of 17667.8%. This contributed to the annual value of -$7.1 million for FY2023, which is N/A changed from last year.
- Per Glucotrack's latest filing, its EBIAT stood at -$879000.0 for Q4 2020, which was down 11366.33% from -$509000.0 recorded in Q3 2020.
- Glucotrack's EBIAT's 5-year high stood at $18.0 million during Q4 2017, with a 5-year trough of -$2.6 million in Q3 2017.
- Its 5-year average for EBIAT is $135961.8, with a median of -$1.1 million in 2016.
- Its EBIAT has fluctuated over the past 5 years, first soared by 168010.73% in 2017, then tumbled by 15529.04% in 2019.
- Quarter analysis of 5 years shows Glucotrack's EBIAT stood at -$1.1 million in 2016, then skyrocketed by 1680.11% to $18.0 million in 2017, then plummeted by 107.4% to -$1.3 million in 2018, then surged by 582.88% to $6.4 million in 2019, then plummeted by 113.66% to -$879000.0 in 2020.
- Its last three reported values are -$879000.0 in Q4 2020, -$509000.0 for Q3 2020, and -$574000.0 during Q2 2020.